Indaptus Therapeutics to Present at HC Wainwright 26th Annual Global Investment Conference Page 1

NEW YORK, Sept. 3, 2024 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) today announced that Jeffrey A. Meckler, Chief Executive Officer, will provide a company overview at the HC Wainwright 26^and Annual Global Investment Conference. The conference will be held from September 9 to 11, 2024 at the Lotte New York Palace Hotel.

A live webcast of the presentation can be accessed via the investor relations section of the Indaptus website. A replay of the webcast will be archived and available for approximately 90 days following the event.